{"id":114,"date":"2017-12-22T16:34:27","date_gmt":"2017-12-22T16:34:27","guid":{"rendered":"http:\/\/clinicalbiochemistry.net\/?page_id=114"},"modified":"2019-01-04T14:35:14","modified_gmt":"2019-01-04T14:35:14","slug":"handbook-of-vascular-biology-techniques","status":"publish","type":"page","link":"http:\/\/clinicalbiochemistry.net\/?page_id=114","title":{"rendered":"Handbook of Vascular Biology Techniques"},"content":{"rendered":"

\"\"<\/strong>The\u00a0<\/span>Handbook of Vascular Biology Techniques, edited by Mark Slevin and Garry McDowell, and published by Springer, contains detailed descriptions of a variety of techniques and methods in both basic and advanced vascular biology. Methodologies range from\u00a0<\/span>in-vitro<\/em>\u00a0cell culture to\u00a0<\/span>in-vivo<\/em>\u00a0manipulations, through cell signalling proteomics and genomics to patient imaging. The book contains a number of novel, state-of-the-art methodologies. Each chapter is fully inclusive, containing sections on trouble shooting and additional notes and links ensuring the reader has sufficient information to execute the protocol without additional requirements.<\/span><\/p>\n

\u00a0<\/p>\n

Contents List<\/a><\/p>\n

HBVBT – Example Chapter<\/a><\/p>\n\nLink to Publisher<\/span><\/a>","protected":false},"excerpt":{"rendered":"

The\u00a0Handbook of Vascular Biology Techniques, edited by Mark Slevin and Garry McDowell, and published by Springer, contains detailed descriptions of a variety of techniques and methods in both basic and advanced vascular biology. Methodologies range from\u00a0in-vitro\u00a0cell culture to\u00a0in-vivo\u00a0manipulations, through cell<\/p>\n","protected":false},"author":1,"featured_media":69,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"jetpack_post_was_ever_published":false,"_links_to":"","_links_to_target":""},"jetpack_shortlink":"https:\/\/wp.me\/P9tPlw-1Q","jetpack-related-posts":[{"id":218,"url":"http:\/\/clinicalbiochemistry.net\/?page_id=218","url_meta":{"origin":114,"position":0},"title":"Book Chapter: ELISA Development","date":"December 27, 2017","format":false,"excerpt":"McDowell, G., Body, R., Kirwan, C., Byrne, G. & Slevin, M. (2015) \u2018A Scheme for the Development and Validation of Enzyme Linked Immunosorbent Assays (ELISA) for Measurement of Angiogenic Biomarkers in Human Blood.\u2019 In: Slevin, M. & McDowell, G. (eds.) (2015) Handbook of Vascular Biology Techniques. London: Springer pp.453-463 (10\u2026","rel":"","context":"Similar post","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":539,"url":"http:\/\/clinicalbiochemistry.net\/?page_id=539","url_meta":{"origin":114,"position":1},"title":"Early Vascular Markers of Acute Coronary Syndromes.","date":"January 11, 2019","format":false,"excerpt":"Purpose: To study the utility of incorporating early vascular activation markers into a clinical decision rule to risk stratify patients according to their risk of a significant myocardial event. Methods:\u00a0We recruited a cohort of patients with symptoms suggest of\u00a0\u00a0ACS presenting to the emergency department. Blood was obtained to determine if\u2026","rel":"","context":"Similar post","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/clinicalbiochemistry.net\/wp-content\/uploads\/2017\/12\/Cardiac-Marker-Test-Pages.png?resize=350%2C200","width":350,"height":200},"classes":[]},{"id":519,"url":"http:\/\/clinicalbiochemistry.net\/?page_id=519","url_meta":{"origin":114,"position":2},"title":"PhD Projects","date":"August 23, 2022","format":false,"excerpt":"We have a range of self funded PhD projects. Please contact us using the details on the adverts below. A Multi-Omics approach to understanding cardiovascular risk in patients with End-Stage Kidney Disease. End-stage Kidney failure, also known as End-stage Kidney Disease (ESKD), is the final, irreversible stage of chronic kidney\u2026","rel":"","context":"Similar post","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/clinicalbiochemistry.net\/wp-content\/uploads\/2019\/02\/iStock_567368_MEDIUM.jpg?resize=350%2C200","width":350,"height":200},"classes":[]},{"id":968,"url":"http:\/\/clinicalbiochemistry.net\/?page_id=968","url_meta":{"origin":114,"position":3},"title":"Self-Funded PhD Opportunity: Cardiovascular Disease in ESRD","date":"August 24, 2022","format":false,"excerpt":"A Multi-Omics approach to understanding cardiovascular risk in patients with End-Stage Kidney Disease. End-stage Kidney failure, also known as End-stage Kidney Disease (ESKD), is the final, irreversible stage of chronic kidney disease, where kidney function has worsened to the point that the kidneys can no longer function independently.\u00a0Cardiovascular complications rather\u2026","rel":"","context":"Similar post","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/clinicalbiochemistry.net\/wp-content\/uploads\/2019\/02\/iStock_17432100_MEDIUM.jpg?resize=350%2C200","width":350,"height":200},"classes":[]},{"id":121,"url":"http:\/\/clinicalbiochemistry.net\/?page_id=121","url_meta":{"origin":114,"position":4},"title":"Research Papers","date":"December 22, 2017","format":false,"excerpt":"Body, R., McDowell, G., Carley, S., Ferguson, J. & Mackway-Jones, K. (2010) \u2018Diagnosing acute myocardial infarction with troponins: how low can you go?\u2019 Emerg Med J. 27 pp. 292-296. Body, R., Carley, S., Wibberley, C., McDowell, G., Ferguson, J. & Mackway- Jones, K. (2010) \u2018The value of symptoms and signs\u2026","rel":"","context":"Similar post","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":49,"url":"http:\/\/clinicalbiochemistry.net\/?page_id=49","url_meta":{"origin":114,"position":5},"title":"Research Expertise","date":"December 17, 2017","format":false,"excerpt":"\u00a0 Research Expertise Cardiology Cardiovascular Disease Acute Cardiology Acute Coronary Syndromes Diagnostics Heart Failure Diagnostics Heart Failure Physiology and Patho-physiology Angiogenesis Cardiac Biomarkers Diagnostic and Prognostic role of Cardiac Biomarkers Methodological Knowledge Immunoassay Point of Care Testing (Near Patient Testing) Cell Biology Clinical Trials Diagnostic Studies Cohort Studies Biomarker development\u2026","rel":"","context":"Similar post","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"http:\/\/clinicalbiochemistry.net\/index.php?rest_route=\/wp\/v2\/pages\/114"}],"collection":[{"href":"http:\/\/clinicalbiochemistry.net\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/clinicalbiochemistry.net\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/clinicalbiochemistry.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/clinicalbiochemistry.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=114"}],"version-history":[{"count":4,"href":"http:\/\/clinicalbiochemistry.net\/index.php?rest_route=\/wp\/v2\/pages\/114\/revisions"}],"predecessor-version":[{"id":527,"href":"http:\/\/clinicalbiochemistry.net\/index.php?rest_route=\/wp\/v2\/pages\/114\/revisions\/527"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/clinicalbiochemistry.net\/index.php?rest_route=\/wp\/v2\/media\/69"}],"wp:attachment":[{"href":"http:\/\/clinicalbiochemistry.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}